BeiGene, Ltd. (ONC) — Capital Reinvestment Ratio
Latest as of March 2026:
0.20x
BeiGene, Ltd. (ONC) has a Capital Reinvestment Ratio of 0.20x as of March 2026, meaning it reinvests 0% of its operating cash flow ($201.94 Million) in capital expenditures ($40.91 Million). See ONC free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.20x
Capex / Operating Cash Flow
Operating Cash Flow
$201.94 Million
USD
Capital Expenditures
$40.91 Million
USD
Data as of
Mar 2026
Most recent filing
BeiGene, Ltd. Capital Reinvestment Ratio (2013–2025)
This chart tracks BeiGene, Ltd.'s Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for BeiGene, Ltd. (2013–2025)
Year-by-year Capital Reinvestment Ratio for BeiGene, Ltd. from 2013 to 2025. For live market cap and broader valuation context, see ONC market cap.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | $1.13 Billion | $185.84 Million | ▼ -96.4% |
| 2017 | 4.61x | $12.75 Million | $58.73 Million | ▲ +7005.2% |
| 2013 | 0.06x | $4.07 Million | $264.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow